MedPath

A study for the impact of immediate breast reconstruction on the prognosis of postoperative breast cancer patients

Not Applicable
Conditions
breast cancer
Registration Number
JPRN-UMIN000043005
Lead Sponsor
Okayama University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
614
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who received neoadjuvant chemotherapy, bilateral breast cancer, scheduled delayed reconstruction or prophylactic mastectomy, diagnosed with clinical stage 4, secondary cancer, breast cancer recurrence, and under 20 years old

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
relapse-free survival
Secondary Outcome Measures
NameTimeMethod
overall survival duration from surgery to initiation of adjuvant chemotherapy
© Copyright 2025. All Rights Reserved by MedPath